Steven M. Paul

Insider Reports History

Location
Indianapolis, IN
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven M. Paul:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Director Common Stock 41.7K $1.04M $24.97 Sep 12, 2025 By Paul Capital Strategy III Fund LLC
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 1K $185K $185.32 Apr 1, 2022 Direct
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 Direct
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 Jann E. Paul GRAT III
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 Jann E Paul Revocable Trust
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 Steve M. Paul Family 2021 Delaware Trust
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 Steven M. Paul Family 2024 Trust
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 The Steven M Paul Revocable Trust
Karuna Therapeutics, Inc. Director Option (right to buy) 0 $0 $142.74 Mar 18, 2024 Direct
Rapport Therapeutics, Inc. Director Stock Option (Right to Buy) 21.9K Jun 17, 2025 Direct
Voyager Therapeutics, Inc. Director Stock Option (Right to Buy) 15K Jun 3, 2021 Direct
Sage Therapeutics, Inc. Director Stock Options (Right to buy) 3.97K Jan 3, 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 0 Apr 1, 2022 Direct

Insider Reports Filed by Steven M. Paul

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAPP Rapport Therapeutics, Inc. Sep 12, 2025 2 $1.03M 4 Sep 15, 2025 Director
RAPP Rapport Therapeutics, Inc. Jun 17, 2025 1 $0 4 Jun 18, 2025 Director
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 Director
KRTX Karuna Therapeutics, Inc. Mar 18, 2024 18 -$830M 4 Mar 18, 2024 Director
KRTX Karuna Therapeutics, Inc. Feb 29, 2024 7 $14.9M 4 Mar 4, 2024 Director
KRTX Karuna Therapeutics, Inc. Feb 23, 2024 4 $600K 4 Feb 26, 2024 Director
KRTX Karuna Therapeutics, Inc. Feb 9, 2024 1 -$255K 4 Feb 12, 2024 Director
SAGE Sage Therapeutics, Inc. Jan 3, 2024 1 $0 4 Jan 4, 2024 Director
SAGE Sage Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
KRTX Karuna Therapeutics, Inc. Feb 9, 2023 6 $0 4 Feb 13, 2023 CSO and President of R&D, Director
SAGE Sage Therapeutics, Inc. Jan 4, 2023 1 $0 4 Jan 5, 2023 Director
SAGE Sage Therapeutics, Inc. Nov 28, 2022 1 $191 4 Nov 30, 2022 Director
SAGE Sage Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Apr 1, 2022 12 -$2.39M 4 Apr 5, 2022 Director
KRTX Karuna Therapeutics, Inc. Feb 16, 2022 1 $0 4 Feb 17, 2022 President & CEO, Director
SAGE Sage Therapeutics, Inc. Jan 4, 2022 1 $0 4 Jan 5, 2022 Director
SAGE Sage Therapeutics, Inc. Nov 9, 2021 1 $43.40 4 Nov 12, 2021 Director
KRTX Karuna Therapeutics, Inc. Aug 17, 2021 2 $250K 4 Aug 18, 2021 PRESIDENT & CEO, Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Jul 15, 2021 1 $0 4 Jul 19, 2021 Director
SAGE Sage Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director
VYGR Voyager Therapeutics, Inc. Jun 3, 2021 1 $0 4 Jun 4, 2021 Director